EndoRings Colonoscopy for Adenoma Detection

Helios Albert-Schweitzer-Klinik Northeim225 enrolled

Overview

Adenoma detection rate (ADR) in colon cancer screening is most important for avoiding colon cancer development. Recent studies suggest a benefit of endoscopic devices attached to the distal tip of the colonoscope for improving the ADR. This work is the first GERMAN randomized controlled trial comparing standard colonoscopy with EndoRIngs-assisted colonoscopy. EndoRings is a new FDA approved device that is attached to the distal tip of the colonoscope. Better Polyp detection is suspected by flattening the mucosal folds during withdrawal

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

SINGLE

Enrollment

225

Conditions

Adenoma

Interventions

EndoRingsDEVICE

EndoRings-assisted colonoscopy

Standard colonoscopyDEVICE

Standard colonoscopy without any additional devices

Eligibility

Sex: ALLMin age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * indication for colonoscopy (screening, surveillance, diagnostic) * age ≥ 45 years * ability to give informed consent Exclusion Criteria: * pregnancy * age \<45 years * known colonic strictures * chronic inflammatory bowel disease * active inflammation * s/p colonic resection * bleeding disorder

Locations (5)

HELIOS HSK Kliniken

Wiesbaden, Hesse, Germany

RECRUITING

Department of Gastroenterology, University Medical Center

Göttingen, Lower Saxony, Germany

RECRUITING

HELIOS St. Marienberg Klinik Helmstedt

Helmstedt, Germany

Outcomes

Primary Outcomes

Adenoma detection rate

Time frame: during colonoscopy

Central Contacts

Tobias Meister, Prof. Dr.

CONTACT

+495551971244 tobias.meister@helios-gesundheit.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.